Company · CIK 1664106

# LogicBio Therapeutics, Inc.

| CIK | [1664106](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001664106) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-12-03 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-234735 | Shelf Effective | 2019-11-15 | 2022-11-18 | 5 |
| 333-227523 | IPO Final prospectus | 2018-09-25 | 2018-10-22 | 6 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2022-11-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1664106/999999999522003341/9999999995-22-003341-index.htm) Declared effective | 333-234735 | 9999999995-22-003341 |
| 2020-10-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1664106/000119312520262477/0001193125-20-262477-index.htm) Shelf takedown | 333-234735 | 0001193125-20-262477 |
| 2020-09-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1664106/000119312520259681/0001193125-20-259681-index.htm) Shelf takedown | 333-234735 | 0001193125-20-259681 |
| 2019-11-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1664106/999999999519002659/9999999995-19-002659-index.htm) Declared effective | 333-234735 | 9999999995-19-002659 |
| 2019-11-15 | [S-3](https://www.sec.gov/Archives/edgar/data/1664106/000119312519293465/0001193125-19-293465-index.htm) Shelf registered | 333-234735 | 0001193125-19-293465 |
| 2018-10-22 | [424B4](https://www.sec.gov/Archives/edgar/data/1664106/000119312518303289/0001193125-18-303289-index.htm) Final prospectus | 333-227523 | 0001193125-18-303289 |
| 2018-10-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1664106/999999999518002661/9999999995-18-002661-index.htm) Declared effective | 333-227523 | 9999999995-18-002661 |
| 2018-10-17 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1664106/000119312518301103/0001193125-18-301103-index.htm) Amendment | 333-227523 | 0001193125-18-301103 |
| 2018-10-11 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1664106/000119312518297645/0001193125-18-297645-index.htm) Amendment | 333-227523 | 0001193125-18-297645 |
| 2018-10-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1664106/000119312518295666/0001193125-18-295666-index.htm) Amendment | 333-227523 | 0001193125-18-295666 |
| 2018-09-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1664106/000119312518282629/0001193125-18-282629-index.htm) Registration filed | 333-227523 | 0001193125-18-282629 |
| 2018-08-13 | [DRS](https://www.sec.gov/Archives/edgar/data/1664106/000095012318008157/0000950123-18-008157-index.htm) Draft made public | 377-02214 | 0000950123-18-008157 |

[All filings of this company](https://equitycapital.markets/filings?cik=1664106) · [CSV](https://equitycapital.markets/filings.csv?cik=1664106)

---
Source page: https://equitycapital.markets/company/1664106 · Data: U.S. SEC EDGAR · CC BY 4.0